Proteinea

Proteinea is an AI-driven biotechnology company engineering next-generation therapeutic antibodies. It integrates protein language models, computational biology and biological automation to design, optimize and validate biologics faster and more safely. Proteinea is the creator of Ankh, an optimized general-purpose protein language model, and operates a Protein Engineering Platform (PEP) for multi-parameter optimization and RaGene for AI-driven codon/gene optimization, with a focus on rational Fc-domain engineering for context-specific immune tuning, enhanced half-life and targeted biodistribution. Headquartered in Cairo, Egypt with offices in Cambridge/ Boston, MA and a presence at KAUST, Saudi Arabia. Backed by 500 Global, IndieBio/SOSV, Shorooq Partners, Sawari Ventures and others. The company exposes research software (open-source models and benchmarks) rather than a public developer API.

Proteinea is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Artificial Intelligence, Machine-Learning, and Protein Engineering.

Proteinea’s developer surface includes support and 5 more developer resources.

7.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyArtificial IntelligenceMachine-LearningProtein EngineeringDrug DiscoveryAntibodiesComputational BiologyOpen-SourceLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 7.5/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.8 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.3 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/proteinea: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Proteinea Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Build 2

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: proteinea
name: Proteinea
description: Proteinea is an AI-driven biotechnology company engineering next-generation therapeutic antibodies. It integrates
  protein language models, computational biology and biological automation to design, optimize and validate biologics faster
  and more safely. Proteinea is the creator of Ankh, an optimized general-purpose protein language model, and operates a Protein
  Engineering Platform (PEP) for multi-parameter optimization and RaGene for AI-driven codon/gene optimization, with a focus
  on rational Fc-domain engineering for context-specific immune tuning, enhanced half-life and targeted biodistribution. Headquartered
  in Cairo, Egypt with offices in Cambridge/ Boston, MA and a presence at KAUST, Saudi Arabia. Backed by 500 Global, IndieBio/SOSV,
  Shorooq Partners, Sawari Ventures and others. The company exposes research software (open-source models and benchmarks)
  rather than a public developer API.
url: https://raw.githubusercontent.com/api-evangelist/proteinea/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://github.com/proteinea.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- 500-global
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Artificial Intelligence
- Machine-Learning
- Protein Engineering
- Drug Discovery
- Antibodies
- Computational Biology
- Open-Source
- Life Sciences
tags_raw:
- Company
- Biotechnology
- Artificial Intelligence
- Machine Learning
- Protein Engineering
- Drug Discovery
- Antibodies
- Computational Biology
- Open Source
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/proteinea-domain-security.yml
- type: Website
  url: https://proteinea.com
- type: GitHubOrganization
  url: https://github.com/proteinea
- type: PrivacyPolicy
  url: https://www.proteinea.com/privacy-policy
- type: Support
  url: https://www.proteinea.com/contact-us
- type: Packages
  url: packages/proteinea-packages.yml
x-enrichment:
  date: '2026-07-20'
  status: enriched
  artifacts_added: 2
  pass: local-v1